Contracts › 75F40123C00118
75F40123C00118: Research Study "Investigating the Impact of Api Purity, Excipient Source and Manufacturing Process on Performance and Quality of Complex Sirna Lipid Nanoparticles".
Awarded to University of Connecticut by Food and Drug Administration (FDA).
$1.5Mobligated
$1.5Mpotential value
21 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40123C00118 |
|---|---|
| Awardee | University of Connecticut |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541720 Research and Development in the Social Sciences and Humanities |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 21 September 2023 to 21 September 2027 |
| Potential end | 21 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541720 contracts · All expiring contracts · USASpending record